{"id":624303,"title":"Multiple additions to the Prescription Drug List (PDL) [2025-10-30]: Notice - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T00:13:42.489000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-10-30.html","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-10-30] October 30, 2025 Our file number: 25-107098-682 The purpose of this Notice of Amendment is to announce the addition of belantamab mafodotin, bulevirtide, delgocitinib, deutivacaftor, elinzanetant,…","rawSnapshotUrl":"/api/snapshots/raw/624303","browseUrl":"https://replay.healtharchive.ca/job-6/20260227001342/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-10-30.html#ha_snapshot=624303","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}